Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02406521
What this trial is testing

Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Mets

Who this might be right for
Metastatic Renal Cell Carcinoma
Dana-Farber Cancer Institute 30
Early research (Phase 1)UnknownNCT05420519
What this trial is testing

Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer

Who this might be right for
Metastatic TumorRenal Cell CarcinomaAdvanced Cancer
Chongqing Precision Biotech Co., Ltd 24
Testing effectiveness (Phase 2)Study completedNCT00045630
What this trial is testing

S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
SWOG Cancer Research Network 77
Large-scale testing (Phase 3)Study completedNCT00073307
What this trial is testing

Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer

Who this might be right for
Carcinoma, Renal Cell
Bayer 903
Testing effectiveness (Phase 2)WithdrawnNCT00003714
What this trial is testing

Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer

Who this might be right for
Liver CancerMetastatic Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01538238
What this trial is testing

Pazopanib_NCRCC,Ph2 STUDY

Who this might be right for
Locally Advanced or Metastatic Non-clear Cell Type Renal Cell Carcinoma
Samsung Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00017329
What this trial is testing

PS-341 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00073879
What this trial is testing

Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Kidney Cancer
Baylor College of Medicine
Testing effectiveness (Phase 2)Study completedNCT01798446
What this trial is testing

A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus

Who this might be right for
Renal Cell CarcinomaNonclear CellTemsirolimus Resistance
Seoul National University Hospital 41
Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Early research (Phase 1)Looking for participantsNCT07187869
What this trial is testing

Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study

Who this might be right for
Clear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT00004203
What this trial is testing

Oxaliplatin in Treating Patients With Metastatic Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
University of Chicago 20
Testing effectiveness (Phase 2)Looking for participantsNCT06889649
What this trial is testing

SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC

Who this might be right for
Radiation TherapyTargeted TherapyImmunotherapy+1 more
Peking University First Hospital 30
Early research (Phase 1)Study completedNCT00098943
What this trial is testing

NGR-TNF in Treating Patients With Advanced Solid Tumors

Who this might be right for
Colorectal CancerHead and Neck CancerKidney Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC 70
Testing effectiveness (Phase 2)UnknownNCT05879497
What this trial is testing

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT03875313
What this trial is testing

Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaTNBC - Triple-Negative Breast Cancer+4 more
Calithera Biosciences, Inc 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT05148546
What this trial is testing

Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer

Who this might be right for
Renal Cell Carcinoma
The Netherlands Cancer Institute 69
Not applicableStudy completedNCT05070637
What this trial is testing

Circulating Tumor Cell Reducing No-touch Nephrectomy

Who this might be right for
Renal Cell CarcinomaCirculating Tumor Cell
Hospital de Santa Maria, Portugal 44
Testing effectiveness (Phase 2)Study completedNCT00422786
What this trial is testing

Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Thallion Pharmaceuticals 10
Post-approval studies (Phase 4)Ended earlyNCT02338570
What this trial is testing

Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE)

Who this might be right for
Renal Cell Carcinoma
Mario Negri Institute for Pharmacological Research 31
Next Page